The neuropsychological assessment battery (NAB) is a valuable tool for evaluating neuropsychological outcome after aneurysmatic subarachnoid hemorrhage
- PMID: 33243170
- PMCID: PMC7689995
- DOI: 10.1186/s12883-020-02003-9
The neuropsychological assessment battery (NAB) is a valuable tool for evaluating neuropsychological outcome after aneurysmatic subarachnoid hemorrhage
Abstract
Background: Detecting and treating neuropsychological deficits after aneurysmatic subarachnoid hemorrhage (aSAH) play a key role in regaining independence; however, detecting deficits relevant to social and professional reintegration has been difficult and optimal timing of assessments remains unclear. Therefore, we evaluated the feasibility of administering the Neuropsychological Assessment Battery screening module (NAB-S) to patients with aSAH, assessed its value in predicting the ability to return to work and characterized clinical as well as neuropsychological recovery over the period of 24 months.
Methods: A total of 104 consecutive patients treated for aSAH were recruited. After acute treatment, follow up visits were conducted at 3, 12 and 24 months after the hemorrhage. NAB-S, Montreal Cognitive Assessment (MoCA) and physical examination were performed at each follow up visit.
Results: The NAB-S could be administered to 64.9, 75.9 and 88.9% of the patients at 3, 12 and 24 months, respectively. Moderate impairment of two or more neuropsychological domains (e.g speech, executive function, etc.) significantly correlated with inability to return to work at 12 and 24 months as well as poor outcome assessed by the extended Glasgow Outcome Scale (GOSE) at 3, 12 and 24 months. The number of patients with favorable outcomes significantly increased from 25.5% at discharge to 56.5 and 57.1% at 3 and 12 months, respectively, and further increased to 74.1% after 24 months.
Conclusion: The NAB-S can be administered to the majority of patients with aSAH and can effectively detect clinically relevant neuropsychological deficits. Clinical recovery after aSAH continues for at least 24 months after the hemorrhage which should be considered in the design of future clinical trials.
Keywords: Aneurysm; Aneurysmatic subarachnoid hemorrhage; Hemorrhagic stroke; Neuropsychological assessment battery; Neuropsychology; Subarachnoid hemorrhage.
Conflict of interest statement
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Similar articles
-
Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage.Neurol Sci. 2020 Apr;41(4):817-824. doi: 10.1007/s10072-019-04159-w. Epub 2019 Dec 4. Neurol Sci. 2020. PMID: 31802342 Free PMC article.
-
Minimum Clinically Important Difference of Montreal Cognitive Assessment in aneurysmal subarachnoid hemorrhage patients.J Clin Neurosci. 2017 Dec;46:41-44. doi: 10.1016/j.jocn.2017.08.039. Epub 2017 Sep 5. J Clin Neurosci. 2017. PMID: 28887072
-
Measuring the Impact of Delayed Cerebral Ischemia on Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage-Protocol of a Swiss Nationwide Observational Study (MoCA-DCI Study).Neurosurgery. 2019 May 1;84(5):1124-1132. doi: 10.1093/neuros/nyy155. Neurosurgery. 2019. PMID: 29762759
-
Cognitive deficits among patients surviving aneurysmal subarachnoid hemorrhage. A contemporary systematic review.Br J Neurosurg. 2021 Aug;35(4):384-401. doi: 10.1080/02688697.2020.1859462. Epub 2020 Dec 21. Br J Neurosurg. 2021. PMID: 33345644
-
Current practice in neuropsychological outcome reporting after aneurysmal subarachnoid haemorrhage.Acta Neurochir (Wien). 2013 Nov;155(11):2045-51. doi: 10.1007/s00701-013-1823-9. Epub 2013 Jul 26. Acta Neurochir (Wien). 2013. PMID: 23887856 Review.
Cited by
-
The Local Intraarterial Administration of Nimodipine Might Positively Affect Clinical Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage and Delayed Cerebral Ischemia.J Clin Med. 2022 Apr 5;11(7):2036. doi: 10.3390/jcm11072036. J Clin Med. 2022. PMID: 35407643 Free PMC article.
-
Long-term outcomes after aneurysmal subarachnoid hemorrhage: A prospective observational cohort study.Acta Neurol Scand. 2022 Nov;146(5):525-536. doi: 10.1111/ane.13674. Epub 2022 Jul 18. Acta Neurol Scand. 2022. PMID: 35852005 Free PMC article.
-
The prognostic value of hyperglycemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.Neurosurg Rev. 2022 Dec;45(6):3717-3728. doi: 10.1007/s10143-022-01870-9. Epub 2022 Sep 28. Neurosurg Rev. 2022. PMID: 36169785
References
-
- Eagles ME, Tso MK, Macdonald RL. Cognitive Impairment, Functional Outcome, and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2019. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical